These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19844127)

  • 1. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1.
    Reininger R; Varga EM; Zach M; Balic N; Lindemeier AD; Swoboda I; Grönlund H; van Hage M; Rumpold H; Valenta R; Spitzauer S
    Clin Exp Allergy; 2007 Jan; 37(1):116-24. PubMed ID: 17210049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of hypoallergens applied to the major cat allergen Fel d 1.
    Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M
    Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fel d 4, a cat lipocalin allergen.
    Smith W; Butler AJ; Hazell LA; Chapman MD; Pomés A; Nickels DG; Thomas WR
    Clin Exp Allergy; 2004 Nov; 34(11):1732-8. PubMed ID: 15544598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cat dander-specific T lymphocytes from atopic patients.
    van Neerven RJ; van de Pol MM; van Milligen FJ; Jansen HM; Aalberse RC; Kapsenberg ML
    J Immunol; 1994 Apr; 152(8):4203-10. PubMed ID: 8144980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.
    Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J
    BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.
    Curin M; Weber M; Thalhamer T; Swoboda I; Focke-Tejkl M; Blatt K; Valent P; Marth K; Garmatiuk T; Grönlund H; Thalhamer J; Spitzauer S; Valenta R
    Clin Exp Allergy; 2014 Jun; 44(6):882-94. PubMed ID: 24552249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.
    Worm M; Lee HH; Kleine-Tebbe J; Hafner RP; Laidler P; Healey D; Buhot C; Verhoef A; Maillère B; Kay AB; Larché M
    J Allergy Clin Immunol; 2011 Jan; 127(1):89-97, 97.e1-14. PubMed ID: 21211644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major cat allergen (Fel d I) levels in the homes of patients with asthma and their relationship to sensitization to cat dander.
    Quirce S; Dimich-Ward H; Chan H; Ferguson A; Becker A; Manfreda J; Simons E; Chan-Yeung M
    Ann Allergy Asthma Immunol; 1995 Oct; 75(4):325-30. PubMed ID: 7583847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of major cat allergen Fel d 1 mimotopes on filamentous phage carriers.
    Luzar J; Molek P; Šilar M; Korošec P; Košnik M; Štrukelj B; Lunder M
    Mol Immunol; 2016 Mar; 71():176-183. PubMed ID: 26908079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Component-resolved microarray analysis of IgE sensitization profiles to Felis catus major allergen molecules in Russian cat-allergic patients.
    Dolgova AS; Sudina AE; Cherkashina AS; Stukolova OA
    Scand J Clin Lab Invest; 2018; 78(1-2):81-86. PubMed ID: 29228796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy.
    Moldaver DM; Bharhani MS; Rudulier CD; Wattie J; Inman MD; Larché M
    J Allergy Clin Immunol; 2019 Mar; 143(3):1087-1099.e4. PubMed ID: 29906527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy.
    van Ree R; van Leeuwen WA; Bulder I; Bond J; Aalberse RC
    J Allergy Clin Immunol; 1999 Dec; 104(6):1223-30. PubMed ID: 10589005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy.
    Martínez-Gómez JM; Johansen P; Rose H; Steiner M; Senti G; Rhyner C; Crameri R; Kündig TM
    Allergy; 2009 Jan; 64(1):172-8. PubMed ID: 19076537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.
    Renand A; Archila LD; McGinty J; Wambre E; Robinson D; Hales BJ; Thomas WR; Kwok WW
    J Allergy Clin Immunol; 2015 Dec; 136(6):1627-1635.e13. PubMed ID: 26371841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
    Couroux P; Patel D; Armstrong K; Larché M; Hafner RP
    Clin Exp Allergy; 2015 May; 45(5):974-981. PubMed ID: 25600085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.
    Niespodziana K; Focke-Tejkl M; Linhart B; Civaj V; Blatt K; Valent P; van Hage M; Grönlund H; Valenta R
    J Allergy Clin Immunol; 2011 Jun; 127(6):1562-70.e6. PubMed ID: 21411130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.